Oncology Trends Impacting the Patient Experience, Trend 3


Advances in oncology care bring greater complexity to patient access and support.

June 16, 2016

The rich pipeline of oncology innovation continues to bring novel treatment options and hope to cancer patients. Advances include an increased number of approved biomarker-directed therapies (with companion diagnostic tests), a growing list of immuno-oncology therapy options, oral therapies that can provide greater patient convenience and a pending wave of biosimilars that may offer less costly alternatives to today's biologics.

Because of ongoing advances, earlier diagnoses and improved oncology care, more cancer patients are surviving for longer periods than ever before. According to the American Cancer Society, there are 14.5 million cancer survivors in the United States today, and this figure is projected to rise to almost 19 million by 2024.1 And with more patients managing their cancer as a chronic condition, the need to properly manage access and adherence in oncology has grown even more pressing.

Access the full ebook to learn more.

And in case you missed Trend 1, addressing oncologist engagement and access, or Trend 2, addressing clinical pathways, download them today.

Now available: 

Trend 4: Patients have higher or different expectations when it comes to their healthcare and treatment options.

Trend 5: Having the right data is more important than ever, but turning data into actionable insights is challenging.

1 American Cancer Society. Life After Cancer: Survivorship by the Numbers. 2013. Accessed 20 May 2016. Available online at


Sign in or register to leave a comment